MREO vs NVDA · $48.7M cap vs P/E 58, rev $215.94B
Mereo BioPharma Group PLC ADR (MREO) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jen-Hsun Huang.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported NVDA revenue for 2026-01-25 was $215.94B. Net income was $120.07B. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
MREO currently screens at market cap $48.7M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the MREO and NVDA stock pages for the full models.
Not investment advice.